scholarly journals Vaniprevir plus peginterferon alfa-2b and ribavirin in treatment-naive Japanese patients with hepatitis C virus genotype 1 infection: a randomized phase III study

2015 ◽  
Vol 51 (4) ◽  
pp. 390-403 ◽  
Author(s):  
Norio Hayashi ◽  
Makoto Nakamuta ◽  
Tetsuo Takehara ◽  
Hiromitsu Kumada ◽  
Akiko Takase ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Japanese Patients ◽  
Phase Iii ◽  
Genotype 1 ◽  
Virus Genotype ◽  
Treatment Naïve ◽  
Phase Iii Study ◽  
Peginterferon Alfa

scholarly journals Vaniprevir plus peginterferon alfa‐2b and ribavirin in treatment‐experienced Japanese patients with hepatitis C virus genotype 1 (GT1b) infection: Phase 3 studies

2016 ◽  
Vol 31 (10) ◽  
pp. 1674-1683 ◽  
Author(s):  
Hiromitsu Kumada ◽  
Satoshi Mochida ◽  
Fumitaka Suzuki ◽  
Kazuaki Chayama ◽  
Yoshiyasu Karino ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Japanese Patients ◽  
Genotype 1 ◽  
Virus Genotype ◽  
Phase 3 ◽  
Peginterferon Alfa

scholarly journals Boceprevir Plus Peginterferon Alfa-2a/Ribavirin in Treatment-Naïve Hepatitis C Virus Genotype 1 Patients: International Phase IIIb/IV TriCo Trial

2016 ◽  
Vol 5 (2) ◽  
pp. 113-124 ◽  
Author(s):  
Peter Ferenci ◽  
Florin A. Caruntu ◽  
Gabriella Lengyel ◽  
Diethelm Messinger ◽  
Georgios Bakalos ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Genotype 1 ◽  
Virus Genotype ◽  
Phase Iiib ◽  
Treatment Naïve ◽  
Peginterferon Alfa

scholarly journals Population pharmacokinetics of paritaprevir, ombitasvir, dasabuvir, ritonavir and ribavirin in hepatitis C virus genotype 1 infection: analysis of six phase III trials

2016 ◽  
Vol 83 (3) ◽  
pp. 527-539 ◽  
Author(s):  
Sven Mensing ◽  
Doerthe Eckert ◽  
Shringi Sharma ◽  
Akshanth R. Polepally ◽  
Amit Khatri ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Population Pharmacokinetics ◽  
Phase Iii ◽  
Genotype 1 ◽  
Virus Genotype ◽  
Phase Iii Trials
Sign in / Sign up

Export Citation Format

Share Document